Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV7E4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,708
Award facts
- Contract value 100% obligated
- $40,707.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,707.81 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pen injections on December 29, 2025, with completion expected by December 30, 2025. This non-set-aside award was issued without competitive restrictions, reflecting AmerisourceBergen's established capability as a critical pharmaceutical supplier to the federal government. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical prime vendor vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor providing essential medications to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company maintains a diversified federal contract portfolio encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Zepbound reflects AmerisourceBergen's role in supplying pharmaceutical products to support military healthcare needs through the DLA's Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DR26FV7E4?
SPE2DR26FV7E4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FV7E4 worth?
The government has obligated $40,708 on SPE2DR26FV7E4.
Is contract SPE2DR26FV7E4 an order under another contract?
Yes. SPE2DR26FV7E4 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7E4 competed?
The extent of competition for SPE2DR26FV7E4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award